Medicare Enrolled
Dr. Mohammed Sabbagh, MD
Hematology · Georgetown, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sabbagh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sabbagh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sabbagh
Dr. Mohammed Sabbagh is a hematology specialist in Georgetown, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Sabbagh performed 2,427 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sabbagh received a total of $20,520 from 92 pharmaceutical and/or device companies across 822 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sabbagh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 15% volume in TX
$20,520 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,427
Medicare services
Top 15% in TX for hematology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,020 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 936 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $99 | $272 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
88 | $107 | $298 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
72 | $24 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $68 | $175 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
36 | $143 | $384 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $121 | $349 |
| New patient office visit, complex (60-74 min) | 12 | $168 | $463 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.6% high complexity
82.2% medium
11.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,520
Total received (2018-2024)
Avg $2,931/year across 7 years
Top 20% in TX for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
822
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,981
2023
$3,427
2022
$2,399
2021
$12
2020
$582
2019
$2,541
2018
$8,577
Payments by company (2024)
Janssen Biotech, Inc.
$556
Merck Sharp & Dohme LLC
$304
AstraZeneca Pharmaceuticals LP
$211
Takeda Pharmaceuticals U.S.A., Inc.
$169
PFIZER INC.
$122
Novartis Pharmaceuticals Corporation
$116
ARRAY BIOPHARMA INC
$108
ABBVIE INC.
$101
Astellas Pharma US Inc
$81
GENZYME CORPORATION
$71
Genentech USA, Inc.
$67
E.R. Squibb & Sons, L.L.C.
$65
Celgene Corporation
$63
TerSera Therapeutics LLC
$62
TAIHO ONCOLOGY, INC.
$57
Lilly USA, LLC
$53
Incyte Corporation
$53
Eisai Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Aveo Pharmaceuticals, Inc.
$48
SOBI, INC
$48
Organon Llc
$47
Ipsen Biopharmaceuticals, Inc
$44
Agios Pharmaceuticals, Inc.
$42
Stemline Therapeutics Inc.
$42
SERVIER PHARMACEUTICALS LLC
$41
Sumitomo Pharma America, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$33
Karyopharm Therapeutics Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
Pharmacosmos Therapeutics Inc.
$25
Azurity Pharmaceuticals, Inc.
$23
EMD Serono, Inc.
$20
ADC Therapeutics America, Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$18
Secura Bio, Inc.
$18
Rigel Pharmaceuticals, Inc.
$17
GlaxoSmithKline, LLC.
$16
Sirtex Medical Inc
$15
Top 3 companies account for 35.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,760
PFIZER INC.
$1,213
Janssen Biotech, Inc.
$1,162
E.R. Squibb & Sons, L.L.C.
$949
Novartis Pharmaceuticals Corporation
$791
Amgen Inc.
$755
Astellas Pharma US Inc
$733
Genentech USA, Inc.
$637
Merck Sharp & Dohme LLC
$545
Takeda Pharmaceuticals U.S.A., Inc.
$438
Incyte Corporation
$426
Merck Sharp & Dohme Corporation
$411
Celgene Corporation
$259
TESARO, Inc.
$228
GENZYME CORPORATION
$209
Exelixis Inc.
$203
ARRAY BIOPHARMA INC
$191
EISAI INC.
$164
ADC Therapeutics America, Inc.
$149
Lilly USA, LLC
$142
ABBVIE INC.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
EMD Serono, Inc.
$139
Gilead Sciences, Inc.
$139
AVEO Pharmaceuticals, Inc.
$133
Seagen Inc.
$133
Boston Scientific Corporation
$132
Eisai Inc.
$132
TerSera Therapeutics LLC
$128
Myriad Genetic Laboratories, Inc.
$128
GlaxoSmithKline, LLC.
$122
Agios Pharmaceuticals, Inc.
$121
Alexion Pharmaceuticals, Inc.
$108
Ipsen Biopharmaceuticals, Inc
$108
SOBI, INC
$107
Bayer HealthCare Pharmaceuticals Inc.
$103
Verastem, Inc.
$92
Daiichi Sankyo Inc.
$82
Karyopharm Therapeutics Inc.
$79
Teva Pharmaceuticals USA, Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$76
TAIHO ONCOLOGY, INC.
$74
Pharmacosmos Therapeutics Inc.
$70
MorphoSys, US Inc.
$68
CTI BioPharma Corp.
$66
Taiho Oncology, Inc.
$65
Stemline Therapeutics Inc.
$60
Seattle Genetics, Inc.
$57
HEMA Biologics, LLC
$55
SERVIER PHARMACEUTICALS LLC
$54
Organon LLC
$53
Regeneron Healthcare Solutions, Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$49
Aveo Pharmaceuticals, Inc.
$48
Celltrion USA Inc.
$47
Organon Llc
$47
Rigel Pharmaceuticals, Inc.
$46
Puma Biotechnology, Inc.
$45
PUMA BIOTECHNOLOGY, INC.
$39
Mylan Institutional Inc.
$39
Sumitomo Pharma America, Inc.
$39
Pharmacyclics LLC, An AbbVie Company
$37
Sirtex Medical Inc
$36
Shield Therapeutics Inc
$36
JAZZ PHARMACEUTICALS INC.
$33
Janssen Pharmaceuticals, Inc
$33
Immunocore Limited
$30
Dova Pharmaceuticals
$29
Azurity Pharmaceuticals, Inc.
$23
Kyowa Kirin, Inc.
$23
Catalyst Pharmaceuticals, Inc.
$23
CSL Behring
$22
Otsuka America Pharmaceutical, Inc.
$22
Mirati Therapeutics, Inc.
$21
AbbVie Inc.
$20
Deciphera Pharmaceuticals Inc.
$20
Blueprint Medicines Corporation
$19
AbbVie, Inc.
$19
Secura Bio, Inc.
$18
Foundation Medicine, Inc.
$18
Spectrum Pharmaceuticals Inc.
$18
Array BioPharma Inc.
$18
Adaptive Biotechnologies Corporation
$17
RECORDATI_RARE_DISEASES_INC.
$17
Servier Pharmaceuticals LLC
$17
Medtronic, Inc.
$15
Emmaus Medical, Inc.
$15
Kite Pharma, Inc.
$14
R-Pharm US LLC
$14
Amneal Pharmaceuticals LLC
$14
Coherus Biosciences Inc.
$14
Clovis Oncology, Inc.
$10
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Avastin · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · Balversa · Bavencio · Blincyto · Braftovi · CALQUENCE · COPIKTRA · CUVITRU · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Endari · Erleada · FIRDAPSE · FOTIVDA · FRUZAQLA · FULPHILA · GAZYVA · GILOTRIF · Haegarda · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTELLIS ADAPTIVESTIM · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · QULIPTA · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SevenFact · SpaceOAR VUE System - 10mL · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truxima · ULTOMIRIS · Udenyca · VEGZELMA · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
1
County median income
$108,309
Nearest hospital to ZIP centroid (approximate)
ROCK SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sabbagh is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sabbagh experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Sabbagh performed 1,020 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sabbagh receive payments from pharmaceutical companies?
Yes. Dr. Sabbagh received a total of $20,520 from 92 companies across 822 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sabbagh's costs compare to other hematologists in Georgetown?
Dr. Sabbagh's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sabbagh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Georgetown
Browse hematologists in Georgetown ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in TX
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in TX
Which TX hematologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology